Executive interview – Riber

Published on 8 May 2019

Chairman Michel Picault begins by explaining what molecular beam epitaxy (MBE) equipment is, what it is used for and what is driving demand. He then discusses Riber’s competitive position. He reviews FY18 performance and concludes with a discussion of why management is very confident about the prospects for FY19.

Share this with friends and colleagues